文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

主动脉瓣置换术后心脏损伤的演变及其预后影响

Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.
PubMed 文献 · J Am Coll Cardiol · 2022-05-17

本研究汇总PARTNER 2与PARTNER 3试验中接受经导管或外科主动脉瓣置换的患者,按基线及1年时心外损伤分期(0–4期)分类,分析损伤变化与2年结局的关系。结果显示基线及1年损伤程度与2年死亡率相关,1年内约15%改善、约60%不变、约25%恶化,损伤分期变化与死亡及死亡或心衰住院复合终点独立相关。

要点

  • 基线及1年心外损伤分期越重,2年死亡风险越高。
  • 1年内损伤改善者死亡风险降低(校正HR 0.49),恶化者升高(校正HR 1.95)。
  • 早期发现主动脉瓣狭窄并在不可逆损伤前干预可能改善预后。

核心结论

  • 主动脉瓣置换患者基线心外损伤范围及其1年变化具有重要预后意义。
  • 早期检出主动脉瓣狭窄并在不可逆心脏损伤发生前干预,可能改善整体心功能与预后。

研究设计与样本

  • 汇总PARTNER 2与PARTNER 3试验中接受经导管或外科主动脉瓣置换的患者,共1,974例。
  • 按基线及1年心外损伤分期(0期无损伤、1期左室损伤、2期左房或二尖瓣损伤、3期肺血管或三尖瓣损伤、4期右室损伤)分类。
  • 采用比例风险模型分析主动脉瓣置换后心脏损伤变化与2年结局的关联。

主要发现

  • 术前分布为0期121例(6.1%)、1期287例(14.5%)、2期1,014例(51.4%)、3期412例(20.9%)、4期140例(7.1%)。
  • 2年死亡率与基线及1年时心脏损伤程度相关。
  • 1年时心脏损伤改善约15%、不变约60%、恶化约25%。
  • 1年损伤分期变化与2年死亡独立相关:改善校正HR 0.49、不变1.00、恶化1.95,P=0.023。
  • 1年损伤分期变化与2年死亡或心衰住院复合终点独立相关:改善校正HR 0.60、不变1.00、恶化2.25,P<0.001。

临床怎么用

  • 对主动脉瓣狭窄患者应关注心外心脏损伤分期,术后1年评估损伤变化有助于风险分层。
  • 损伤恶化者死亡及心衰住院风险升高,或需更密切随访与强化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of aortic valve replacement (AVR) on progression/regression of extravalvular cardiac damage and its association with subsequent prognosis is unknown. OBJECTIVES: The purpose of this study was to describe the evolution of cardiac damage post-AVR and its association with outcomes. METHODS: Patients undergoing transcatheter or surgical AVR from the PARTNER (Placement of Aortic Transcatheter Valves) 2 and 3 trials were pooled and classified by cardiac damage stage at baseline and 1 year (stage 0, no damage; stage 1, left ventricular damage; stage 2, left atrial or mitral valve damage; stage 3, pulmonary vasculature or tricuspid valve damage; and stage 4, right ventricular damage). Proportional hazards models determined association between change in cardiac damage post-AVR and 2-year outcomes. RESULTS: Among 1,974 patients, 121 (6.1%) were stage 0, 287 (14.5%) stage 1, 1,014 (51.4%) stage 2, 412 (20.9%) stage 3, and 140 (7.1%) stage 4 pre-AVR. Two-year mortality was associated with extent of cardiac damage at baseline and 1 year. Compared with baseline, cardiac damage improved in ∼15%, remained unchanged in ∼60%, and worsened in ∼25% of patients at 1 year. The 1-year change in cardiac damage stage was independently associated with mortality (adjusted HR for improvement: 0.49; no change: 1.00; worsening: 1.95; P = 0.023) and composite of death or heart failure hospitalization (adjusted HR for improvement: 0.60; no change: 1.00; worsening: 2.25; P < 0.001) at 2 years. CONCLUSIONS: In patients undergoing AVR, extent of extravalvular cardiac damage at baseline and its change at 1 year have important prognostic implications. These findings suggest that earlier detection of aortic stenosis and intervention before development of irreversible cardiac damage may improve global cardiac function and prognosis. (PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk [PII A], NCT01314313; The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B [PARTNERII B], NCT02184442; and PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis [P3], NCT02675114).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Généreux P, Pibarot P, Redfors B, et al. Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement. J Am Coll Cardiol. 2022. PMID: 35595203. doi:10.1016/j.jacc.2022.05.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。